Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
GNTbm's Trial on New Epigenetic Drug Generates Hope for Patients with Breast Cancer
Breast cancer is the most common cancer in women worldwide, especially in Taiwan. In 2018, Taiwan recorded 14,127 […]
Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, […]
Implicity Launches a Solution to Improve Remote Monitoring of Heart Failure Patients
Implicity, a leader in remote patient monitoring software and cardiac data management solutions, announced the […]
Capsida Biotherapeutics Unveils Next-Generation Gene Therapy Manufacturing
Capsida Biotherapeutics Inc., a fully integrated biotechnology company creating a new class of targeted adeno-associated […]
Lumira Ventures Closes on US$255 Million of New Capital to Build Transformative Healthcare Companies
Lumira Ventures today announced a significant expansion of its capital base to support the founding […]
Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of Covid-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government […]
Fujitsu Launches Solution Which Supports Cloud-based Epic EPRs
Fujitsu has launched a solution which will allow NHS trusts and other healthcare organisations in […]
Novo Holdings Co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Novo Holdings, a leading international life science investor, today announces that it has co-led alongside […]
Peer-reviewed Research Finds Babylon's Digital-first Model of Primary Care is Associated With Lower Significantly NHS Hospital Care Costs
Researchers at Babylon, a leading digital-first value-based healthcare company, have found that members of Babylon’s […]
Vaxzevria is Highly Effective After One Dose Against Severe Disease or Hospitalisation Caused by Beta and Delta Variants of Concern
Results from the Canadian Immunization Research Network (CIRN) with support from Public Health Agency of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more